540 related articles for article (PubMed ID: 29904022)
1. Designer Oncolytic Adenovirus: Coming of Age.
Baker AT; Aguirre-Hernández C; Halldén G; Parker AL
Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29904022
[TBL] [Abstract][Full Text] [Related]
2. Ad5
Uusi-Kerttula H; Davies JA; Thompson JM; Wongthida P; Evgin L; Shim KG; Bradshaw A; Baker AT; Rizkallah PJ; Jones R; Hanna L; Hudson E; Vile RG; Chester JD; Parker AL
Clin Cancer Res; 2018 Sep; 24(17):4215-4224. PubMed ID: 29798908
[No Abstract] [Full Text] [Related]
3. The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines.
Kloker LD; Berchtold S; Smirnow I; Schaller M; Fehrenbacher B; Krieg A; Sipos B; Lauer UM
Neuroendocrinology; 2019; 109(4):346-361. PubMed ID: 31280274
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral Immunotherapy-Update 2019.
Hamid O; Ismail R; Puzanov I
Oncologist; 2020 Mar; 25(3):e423-e438. PubMed ID: 32162802
[TBL] [Abstract][Full Text] [Related]
5. A Renaissance for Oncolytic Adenoviruses?
Blanchette P; Teodoro JG
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851572
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy.
Kohlhapp FJ; Kaufman HL
Clin Cancer Res; 2016 Mar; 22(5):1048-54. PubMed ID: 26719429
[TBL] [Abstract][Full Text] [Related]
7. Concepts in Oncolytic Adenovirus Therapy.
Mantwill K; Klein FG; Wang D; Hindupur SV; Ehrenfeld M; Holm PS; Nawroth R
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638863
[TBL] [Abstract][Full Text] [Related]
8. Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma.
Bommareddy PK; Patel A; Hossain S; Kaufman HL
Am J Clin Dermatol; 2017 Feb; 18(1):1-15. PubMed ID: 27988837
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus and Immunotherapy: Advancing Cancer Treatment by Combination.
Sato-Dahlman M; LaRocca CJ; Yanagiba C; Yamamoto M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455560
[TBL] [Abstract][Full Text] [Related]
10. Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses.
Schierer S; Hesse A; Müller I; Kämpgen E; Curiel DT; Schuler G; Steinkasserer A; Nettelbeck DM
Int J Cancer; 2008 Jan; 122(1):219-29. PubMed ID: 17764070
[TBL] [Abstract][Full Text] [Related]
11. Determinants of combination GM-CSF immunotherapy and oncolytic virotherapy success identified through in silico treatment personalization.
Cassidy T; Craig M
PLoS Comput Biol; 2019 Nov; 15(11):e1007495. PubMed ID: 31774808
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses.
Goradel NH; Alizadeh A; Hosseinzadeh S; Taghipour M; Ghesmati Z; Arashkia A; Negahdari B
Future Oncol; 2022 Jan; 18(2):245-259. PubMed ID: 34821517
[TBL] [Abstract][Full Text] [Related]
13. Talimogene Laherparepvec: An Oncolytic Virus Therapy for Melanoma.
Corrigan PA; Beaulieu C; Patel RB; Lowe DK
Ann Pharmacother; 2017 Aug; 51(8):675-681. PubMed ID: 28351167
[TBL] [Abstract][Full Text] [Related]
14. Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model.
Uche IK; Fowlkes N; Vu L; Watanabe T; Carossino M; Nabi R; Del Piero F; Rudd JS; Kousoulas KG; Rider PJF
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177208
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy.
Wang X; Shen Y; Wan X; Hu X; Cai WQ; Wu Z; Xin Q; Liu X; Gui J; Xin HY; Xin HW
J Transl Med; 2023 Jul; 21(1):500. PubMed ID: 37491263
[TBL] [Abstract][Full Text] [Related]
17. From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.
Kabiljo J; Laengle J; Bergmann M
Cell Death Discov; 2020; 6():48. PubMed ID: 32542113
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic virus therapy: A new era of cancer treatment at dawn.
Fukuhara H; Ino Y; Todo T
Cancer Sci; 2016 Oct; 107(10):1373-1379. PubMed ID: 27486853
[TBL] [Abstract][Full Text] [Related]
19. Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies.
Cunliffe TG; Bates EA; Parker AL
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33187160
[TBL] [Abstract][Full Text] [Related]
20. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches.
Ji Q; Wu Y; Albers A; Fang M; Qian X
Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
